If a diabetic patient being treated with an oral hypoglycemicagent, evelopsdilutional hyponatermia, which one of the following could be responsible for this effect-
**Question:** If a diabetic patient being treated with an oral hypoglycemic agent develops dilutional hyponatremia, which one of the following could be responsible for this effect:
A. Diuretic
B. Sodium channel blocker
C. Sulfonylurea
D. Biguanide
**Core Concept:**
Diabetic patients on oral hypoglycemic agents may develop dilutional hyponatremia, a condition where the serum sodium level decreases due to an excess of extracellular fluid (ECF) without a corresponding decrease in serum osmolality. This can result from inappropriate secretion of antidiuretic hormone (ADH) by the posterior pituitary gland, leading to excessive water reabsorption in the nephrons and increased ECF volume.
**Why the Correct Answer is Right:**
The correct answer is D - Biguanide. Biguanides, such as metformin, are a class of oral hypoglycemic agents used for the management of type 2 diabetes. They act by reducing hepatic glucose production and enhancing peripheral glucose uptake, ultimately lowering blood glucose levels.
**Why Each Wrong Option is Incorrect:**
A. Diuretic (option A): Diuretics are drugs that increase urine production and decrease ECF volume, leading to hyponatremia. In contrast, biguanides cause a decrease in renal water reabsorption and do not lead to dilutional hyponatremia.
B. Sodium channel blocker (option B): Sodium channel blockers are medications that hinder sodium reabsorption in the nephrons, leading to a decrease in ECF volume and subsequently reducing the risk of dilutional hyponatremia. Biguanides, on the other hand, increase renal water excretion, making them less likely to cause dilutional hyponatremia.
C. Sulfonylurea (option C): Sulfonylureas stimulate insulin secretion, lowering blood glucose levels, but do not cause dilutional hyponatremia due to their mechanism of action.
**Clinical Pearl:**
Dilutional hyponatremia occurs in patients taking medications that increase ECF volume, such as diuretics or options A, B, and C. Biguanides, like metformin, are generally safe in terms of causing dilutional hyponatremia due to their mechanism of action, which is different from the mechanisms of the other options.